Supplementary Table 4 from Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer
收藏数据链接：
官方服务：
资源简介：
Table 4a. Fold-change values for each signature between Response and No Response based on physical examination, pathology or imagingTable 4b. Fold-change values for significantly differentially expressed genes between Response and No Response based on physical examination, pathology or imaging
创建时间：
2023-08-10
